Bumper Offer - Urjas oil Just @ Rs. 1
SUCRAL ANO CREAM 20GM, a prescription drug, is manufactured in various forms such as Cream. It is primarily used for the treatment of Peptic Ulcer. Other than this, SUCRAL ANO CREAM 20GM has some other therapeutic uses, which have been discussed ahead.
The correct dosage of SUCRAL ANO CREAM 20GM depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of SUCRAL ANO CREAM 20GM are Constipation. Besides the aforementioned side effects, there are other adverse effects of SUCRAL ANO CREAM 20GM as well, which are listed below. Such side effects of SUCRAL ANO CREAM 20GM normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, SUCRAL ANO CREAM 20GM's effect is Unknown during pregnancy and Unknown for lactating mothers. In addition, SUCRAL ANO CREAM 20GM's effects on the liver, heart and kidney are discussed below in the SUCRAL ANO CREAM 20GM related warnings section.
SUCRAL ANO CREAM 20GM is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes are examples of such conditions. The section on SUCRAL ANO CREAM 20GM contraindications lists all such conditions.
Drug interactions for SUCRAL ANO CREAM 20GM have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that SUCRAL ANO CREAM 20GM is not safe while driving, and is is not addictive in nature.
SUCRAL ANO CREAM 20GM is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when SUCRAL ANO CREAM 20GM is used -
Moderate
Mild
Common
Is the use of SUCRAL ANO CREAM 20GM safe for pregnant women?
The effects of Sucral on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of SUCRAL ANO CREAM 20GM safe during breastfeeding?
Information about safety of Sucral for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of SUCRAL ANO CREAM 20GM on the Kidneys?
Sucral rarely harms the kidneys.
What is the effect of SUCRAL ANO CREAM 20GM on the Liver?
Sucral does not damage the liver.
What is the effect of SUCRAL ANO CREAM 20GM on the Heart?
You can take Sucral without any fear of damage to the heart.
SUCRAL ANO CREAM 20GM should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take SUCRAL ANO CREAM 20GM unless your doctor advises you to do so -
Is this SUCRAL ANO CREAM 20GM habit forming or addictive?
SUCRAL ANO CREAM 20GM is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking SUCRAL ANO CREAM 20GM you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
SUCRAL ANO CREAM 20GM is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking SUCRAL ANO CREAM 20GM for mental disorders.
Interaction between Food and SUCRAL ANO CREAM 20GM
It is safe to take SUCRAL ANO CREAM 20GM with food.
Interaction between Alcohol and SUCRAL ANO CREAM 20GM
Information about the interaction of SUCRAL ANO CREAM 20GM and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
